Australian Mother Threatens Class-Action Against TGA Over Zoloft
This article was originally published in PharmAsia News
Executive Summary
The mother of an Australian girl alleged to have become suicidal after taking Pfizer's Zoloft (sertraline) is considering a suit against the country's drug regulator. The mother settled her $59,000 suit against the physician who prescribed the drug. She said she was contemplating a class-action suit against the Therapeutic Goods Administration on grounds it did not advise the public anti-depressant drugs have risks. The suit against the doctor alleged he falsely promoted Zoloft, the daughter attempted suicide, and the mother had to quit her job to care for the 16 year old. It was discovered the girl had a genetic defect that caused her to have adverse reactions to the sertraline. (Click here for more
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.